Frontier Capital Management CO LLC Adaptimmune Therapeutics PLC Transaction History

Frontier Capital Management CO LLC

  • $10.2 Billion
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Jan 25, 2019
SELL
$3.76 - $14.16 $2.63 Million - $9.89 Million
-698,694 Closed
0 $0
Q3 2018

Oct 30, 2018
BUY
$8.27 - $13.56 $4.5 Million - $7.37 Million
543,809 Added 351.11%
698,694 $9.47 Million
Q2 2018

Aug 03, 2018
BUY
$10.42 - $13.74 $1.61 Million - $2.13 Million
154,885 New
154,885 $1.84 Million

Others Institutions Holding ADAP

# of Institutions
84
Shares Held
160M
Call Options Held
42.8K
Put Options Held
42.1K
View Full List

About Adaptimmune Therapeutics PLC

ADAP Quotes by TradingView
  • Ticker ADAP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 163,370,000
  • Market Cap $160M
  • Description
  • Adaptimmune Therapeutics plc, a clinical-stage biopharmaceutical company, focuses on providing novel cell therapies primarily to patients with solid tumors in the United States and the United Kingdom. The company's specific peptide enhanced affinity receptor (SPEAR) T-cell platform enables it to identify cancer targets. It is developing ADP-A2M4...
More about ADAP
Track This Portfolio

Track Frontier Capital Management CO LLC Portfolio

Follow Frontier Capital Management CO LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Frontier Capital Management CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Frontier Capital Management CO LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email